Skip to main content
. 2020 May 14;7:74. doi: 10.3389/fcvm.2020.00074

Table 2.

30-day adverse events.

All n = 166
Reinfarction 8 (5%)
Definite stent thrombosis 3 (2%)
Ischemic stroke 1 (1%)
Haemorrhagic stroke 3 (2%)
Peripheral ischemia of the leg requiring Surgery or intervention 15 (9%)
Haemolysis 31 (19%)
Bleeding (based on GUSTO definitions (25))
    Life-threatening/severe 9 (5%)
    Moderate 27 (16%)
    Mild 33 (20%)
Sepsis 50 (30%)
Renal replacement therapy 84 (51%)